Cargando…

The prognostic value of (18)F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients

BACKGROUND: Neuroblastoma (NB) is the most common tumour in children younger than 5 years old and notable for highly heterogeneous. Our aim was to quantify the intra-tumoural metabolic heterogeneity of primary tumour lesions by using (18)F-FDG PET/CT and evaluate the prognostic value of intra-tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jun, Si, Yukun, Zhou, Ziang, Yang, Xu, Li, Cuicui, Qian, Luodan, Feng, Li Juan, Zhang, Mingyu, Zhang, Shu Xin, Liu, Jie, Kan, Ying, Gong, Jianhua, Yang, Jigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254530/ https://www.ncbi.nlm.nih.gov/pubmed/35791003 http://dx.doi.org/10.1186/s40644-022-00472-4

Ejemplares similares

The Diagnostic Value of (18)F-FDG PET/CT Bone Marrow Uptake Pattern in Detecting Bone Marrow Involvement in Pediatric Neuroblastoma Patients
por: Liu, Jun, et al.
Publicado: (2022)

Evaluation of iodine-123-labeled metaiodobenzylguanidine single-photon emission computed tomography/computed tomography based on the International Society of Pediatric Oncology Europe Neuroblastoma score in children with neuroblastoma
por: Zhou, Ziang, et al.
Publicado: (2023)

Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma via Pre-therapy 18F-FDG PET/CT Radiomics
por: Qian, Luodan, et al.
Publicado: (2022)

Prediction for Mitosis-Karyorrhexis Index Status of Pediatric Neuroblastoma via Machine Learning Based (18)F-FDG PET/CT Radiomics
por: Feng, Lijuan, et al.
Publicado: (2022)

(18)F-FDG PET/CT-based radiomics nomogram could predict bone marrow involvement in pediatric neuroblastoma
por: Feng, Lijuan, et al.
Publicado: (2022)

Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma
por: Feng, Lijuan, et al.
Publicado: (2022)

(18)F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification
por: Qian, Luo-Dan, et al.
Publicado: (2022)

Nuclear Factor-κB Activating Protein Plays an Oncogenic Role in Neuroblastoma Tumorigenesis and Recurrence Through the Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway
por: Liu, Jun, et al.
Publicado: (2021)

Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma
por: Man, Shuai, et al.
Publicado: (2021)

Development and Validation of (18)F-FDG PET/CT-Based Multivariable Clinical Prediction Models for the Identification of Malignancy-Associated Hemophagocytic Lymphohistiocytosis
por: Yang, Xu, et al.
Publicado: (2022)

Development and Validation of a Nomogram Based on (18)F-FDG PET/CT Radiomics to Predict the Overall Survival in Adult Hemophagocytic Lymphohistiocytosis
por: Yang, Xu, et al.
Publicado: (2021)

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
por: López-Carrasco, Amparo, et al.
Publicado: (2021)

The Role of Pre-therapeutic (18)F-FDG PET/CT in Pediatric Hemophagocytic Lymphohistiocytosis With Epstein-Barr Virus Infection
por: Lu, Xia, et al.
Publicado: (2022)

The baseline metabolism parameters of (18)F‑FDG PET/CT as promising prognostic biomarkers in pediatric Langerhans cell histiocytosis
por: Lu, Xia, et al.
Publicado: (2023)

Multiparameter diagnostic model based on (18)F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomas
por: Wang, Guanyun, et al.
Publicado: (2022)

Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature
por: Qian, Luo-Dan, et al.
Publicado: (2023)

Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer
por: Li, Yi, et al.
Publicado: (2021)

Prognostic prediction by (18)F-FDG-PET/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis
por: Hu, Ruimin, et al.
Publicado: (2023)

123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients
por: Zhang, Mingyu, et al.
Publicado: (2021)

Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas
por: Liu, Dao-ning, et al.
Publicado: (2018)

Intra-operative use of PET probe for localization of FDG avid lesions
por: Molina, M.A., et al.
Publicado: (2009)

Pretreatment (18)F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal Cancer
por: He, Peng, et al.
Publicado: (2021)

Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma
por: Li, Chao, et al.
Publicado: (2022)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

(18)F-FDG PET/CT for Identifying the Potential Primary Diseases and Predicting Prognosis of Secondary Hemophagocytic Lymphohistiocytosis in Children
por: Wei, Ang, et al.
Publicado: (2022)

Heterogeneity of neuroblastoma
por: Ngan, Elly Sau-Wai
Publicado: (2015)

Texture analysis of pretreatment [(18)F]FDG PET/CT for the prognostic prediction of locally advanced salivary gland carcinoma treated with interstitial brachytherapy
por: Wu, Wen-Jie, et al.
Publicado: (2019)

Intra-abdominal desmoplastic small round cell tumors: CT and FDG-PET/CT findings with histopathological association
por: CHEN, JINGJING, et al.
Publicado: (2016)

Pretreatment (18) F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study
por: Yang, Zhongyi, et al.
Publicado: (2015)

The Role of Pretreatment (18)F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yao, Jijin, et al.
Publicado: (2021)

Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET/CT Parameters in Primary Gastric DLBCL
por: Albano, Domenico, et al.
Publicado: (2021)

The Efficacy of Pretreatment (18)F-FDG PET-CT-Based Deep Learning Network Structure to Predict Survival in Nasopharyngeal Carcinoma
por: Long, Zi-chan, et al.
Publicado: (2023)

The significance of (18)F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis
por: Zhang, Li-Juan, et al.
Publicado: (2012)

Development and validation of a [(18)F]FDG PET/CT-based radiomics nomogram to predict the prognostic risk of pretreatment diffuse large B cell lymphoma patients
por: Li, Mingshan, et al.
Publicado: (2022)

A new assessment model for tumor heterogeneity analysis with [18]F-FDG PET images
por: Wang, Ping, et al.
Publicado: (2016)

Cancer-associated fibroblasts enhance tumor (18)F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT
por: Shangguan, Chengfang, et al.
Publicado: (2018)

Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
por: Liu, Yi, et al.
Publicado: (2019)

Comparison between an SGLT2 inhibitor and insulin in tumor-to-tissue contrasts in (18)F-FDG PET imaging of diabetic mice
por: Meidai, Liang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s957rfrq2ivfj0764ogt0e26jv